IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
B Valamehr, R Bjordahl, TT Lee… - US Patent App. 16 …, 2021 - Google Patents
2020-05-29 Assigned to FATE THERAPEUTICS, INC. reassignment FATE THERAPEUTICS,
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS) …
Immune effector cell therapies with enhanced efficacy
G Motz, KJ Mavrakias, J Liu, L Liu, Q Zheng… - US Patent App. 16 …, 2019 - Google Patents
XSCKKJUTVFZNQP-UHFFFAOYSA-N CN (C) C1CCN (S (= O)(= O) C2= CC= C (N3N=
CC4= C3C= CC= C4C3= CC= C (C4CCNCC4) C= C3) C= C2) CC1 Chemical compound …
CC4= C3C= CC= C4C3= CC= C (C4CCNCC4) C= C3) C= C2) CC1 Chemical compound …
Immune effector cell therapies with enhanced efficacy
G Motz, KJ Mavrakias, J Liu, L Liu, Q Zheng… - US Patent App. 16 …, 2019 - Google Patents
2020-06-17 Assigned to CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH
CO., LTD reassignment CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH …
CO., LTD reassignment CHINA NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH …
CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS
B Valamehr, TT Lee, A Witty, M Pribadi - US Patent App. 17/438,317, 2022 - Google Patents
US20220184142A1 - CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE
EFFECTOR CELLS - Google Patents US20220184142A1 - CD3 RECONSTITUTION IN …
EFFECTOR CELLS - Google Patents US20220184142A1 - CD3 RECONSTITUTION IN …
Engineered immune effector cells and use thereof
B Valamehr, R Bjordahl, J Goodridge… - US Patent App. 17 …, 2021 - Google Patents
US20210024959A1 - Engineered immune effector cells and use thereof - Google Patents
US20210024959A1 - Engineered immune effector cells and use thereof - Google Patents …
US20210024959A1 - Engineered immune effector cells and use thereof - Google Patents …
Methods of cancer treatment using activated T cells
X Zhou, J Li, HAN Yanyan, WU Dongyun… - US Patent …, 2022 - Google Patents
2021-01-08 Assigned to SYZ CELL THERAPY CO. reassignment SYZ CELL THERAPY CO.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Methods of cancer treatment using activated T cells
X Zhou, J Li, HAN Yanyan, WU Dongyun… - US Patent …, 2021 - Google Patents
2019-04-30 Assigned to SYZ CELL THERAPY CO. reassignment SYZ CELL THERAPY CO.
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors …
Methods for dosing and treatment of b cell malignancies in adoptive cell therapy
H Gillenwater, T Albertson, J Thorpe… - US Patent App. 17 …, 2022 - Google Patents
2021-06-25 Assigned to JUNO THERAPEUTICS, INC. reassignment JUNO
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR …
IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS
B Valamehr, R Bjordahl, TT Lee - US Patent App. 17/297,805, 2022 - Google Patents
Provided are methods and compositions for obtaining functionally enhanced derivative
effector cells obtained from directed differentiation of genomically engineered iPSCs. The …
effector cells obtained from directed differentiation of genomically engineered iPSCs. The …
Methods for enhancing efficacy of therapeutic immune cells
D Campana, T Kamiya - 2016 - Google Patents
2021-12-28 First worldwide family litigation filed litigation Critical https://patents. darts-ip.
com/? family= 56564429&utm_source= google_patent&utm_medium …
com/? family= 56564429&utm_source= google_patent&utm_medium …